Growth Metrics

CorMedix (CRMD) Total Liabilities (2016 - 2025)

CorMedix (CRMD) has disclosed Total Liabilities for 14 consecutive years, with $420.8 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 1130.91% to $420.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $420.8 million through Dec 2025, up 1130.91% year-over-year, with the annual reading at $420.8 million for FY2025, 1130.91% up from the prior year.
  • Total Liabilities hit $420.8 million in Q4 2025 for CorMedix, up from $376.7 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $420.8 million in Q4 2025 to a low of $3.9 million in Q1 2021.
  • Historically, Total Liabilities has averaged $52.9 million across 5 years, with a median of $8.0 million in 2023.
  • Biggest five-year swings in Total Liabilities: tumbled 32.08% in 2021 and later soared 1896.05% in 2025.
  • Year by year, Total Liabilities stood at $6.1 million in 2021, then increased by 13.52% to $7.0 million in 2022, then increased by 17.89% to $8.2 million in 2023, then skyrocketed by 315.56% to $34.2 million in 2024, then surged by 1130.91% to $420.8 million in 2025.
  • Business Quant data shows Total Liabilities for CRMD at $420.8 million in Q4 2025, $376.7 million in Q3 2025, and $32.0 million in Q2 2025.